Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000548366 | SCV000643656 | uncertain significance | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2017-07-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002384159 | SCV002674931 | uncertain significance | Cardiovascular phenotype | 2019-08-26 | criteria provided, single submitter | clinical testing | The p.R2444L variant (also known as c.7331G>T), located in coding exon 30 of the TTN gene, results from a G to T substitution at nucleotide position 7331. The arginine at codon 2444 is replaced by leucine, an amino acid with dissimilar properties. This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Revvity Omics, |
RCV003139826 | SCV003822879 | uncertain significance | not provided | 2019-09-06 | criteria provided, single submitter | clinical testing | |
Greenwood Genetic Center Diagnostic Laboratories, |
RCV003139826 | SCV003932161 | uncertain significance | not provided | 2023-03-01 | criteria provided, single submitter | clinical testing | PM2, PP3 |